Physician profile

Kyle White

Family · Sierra Vista, AZ

NPI 1497293328

$15,029.92

in general payments reported to CMS, 2019-2025

37 companies · $1,435 in 2025

The $1,435 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,969.29
Travel and Lodging$1,968.55
Education$45.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $4,560.21 2021-2025 Eterna, Proclaim
Medtronic, INC. $4,070.58 2021-2025 Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim
Pacira Pharmaceuticals Incorporated $1,176.40 2024 Iovera
Collegium Pharmaceutical, INC. $772.02 2021-2025 Belbuca, Xtampza
Abbvie INC. $739.21 2021-2025
Biodelivery Sciences International, INC. $672.69 2021
Boston Scientific Corporation $471.66 2022-2025 Wavewriter Alpha Prime 16, Intracept, General - Pain Management
Allergan, INC. $317.65 2021
Amgen INC. $252.59 2021-2025 Evenity, Prolia
Globus Medical, INC. $239.48 2025 Senza
Spr Therapeutics, INC $178.86 2023 Sprint Pns System
Pfizer INC. $170.60 2021-2025
Nalu Medical, INC. $155.15 2021-2022
Lundbeck LLC $154.31 2022-2025 Vyepti
Vertex Pharmaceuticals Incorporated $114.78 2025
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Saluda Medical Americas, INC. $112.70 2025 Evoke
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $89.94 2024-2025 Relistor
Teva Pharmaceuticals USA, INC. $81.45 2021-2025 Ajovy
Biohaven Pharmaceuticals, INC. $78.97 2021
Nevro Corp. $77.09 2022-2023 Senza
Lilly USA, LLC $72.52 2021-2022
Biohaven Pharmaceutical Holding Company LTD. $46.62 2022
Biotronik Nro, INC. $43.03 2024 Prospera
Scilex Pharmaceuticals INC. $41.32 2021-2023 Ztlido
Pacira Therapeutics, INC. $41.02 2021
Merz Pharmaceuticals, LLC $40.17 2025 Xeomin
Microtransponder, INC. $38.20 2024
Eisai INC. $34.53 2021-2022
Amneal Pharmaceuticals LLC $28.44 2022
Piramal Critical Care $24.57 2023
Ibsa Pharma INC. $24.00 2023 Tirosint, Licart
Tonix Medicines, INC. $22.54 2025 Tonmya
Tersera Therapeutics LLC $20.15 2022
Averitas Pharma INC. $18.20 2023 Qutenza
Novartis Pharmaceuticals Corporation $17.03 2021
Almatica Pharma LLC $15.89 2022
International Rehabilitative Sciences, INC $15.35 2024 Rs 4i Plus Sequential Stimulator

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kyle White

$15,029.92

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbott Laboratories
Context
The $1,435 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/10485719/kyle-white

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.